1,340
Views
27
CrossRef citations to date
0
Altmetric
Review Articles

Relative effectiveness of augmentation treatments for treatment-resistant depression: a systematic review and network meta-analysis

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 477-490 | Received 20 Jan 2020, Accepted 04 May 2020, Published online: 05 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Brett D.M. Jones, M. Ishrat Husain & Benoit H. Mulsant. (2021) The use of sequential pharmacotherapy for the treatment of acute major depression: a scoping review. Expert Opinion on Pharmacotherapy 22:8, pages 1005-1014.
Read now
HyeJin Park, Chan Mi Park, Jong-Min Woo, Ju-Young Shin, Eui-Kyung Lee & Sun-Hong Kwon. (2021) Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants. Journal of Medical Economics 24:1, pages 589-597.
Read now
Gang Wang, Changsu Han, Chia-Yih Liu, Sandra Chan, Tadafumi Kato, Wilson Tan, Lili Zhang, Yu Feng & Chee H Ng. (2020) Management of Treatment-Resistant Depression in Real-World Clinical Practice Settings Across Asia. Neuropsychiatric Disease and Treatment 16, pages 2943-2959.
Read now

Articles from other publishers (24)

Karniza Khalid, Wei Chern Ang, Aimi Izwani Mohd. Nazli, Ruzita Jamaluddin & Syed A. A. Rizvi. (2023) Predictors of Treatment Response in Patients with Treatment-Resistant Depression: Outcomes of a Randomized Trial. Psychiatry International 4:3, pages 246-254.
Crossref
Muhammad Ishrat Husain, Daniel M. Blumberger, David J. Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat & Benoit H. Mulsant. (2023) Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. BJPsych Open 9:4.
Crossref
Mark Zimmerman & Daniel M. Mackin. (2023) Reliability and validity of the difficult to treat depression questionnaire (DTDQ). Psychiatry Research 324, pages 115225.
Crossref
Antonio Tundo, Sophia Betro’, Rocco de Filippis, Fulvia Marchetti, Daniele Nacca, Roberta Necci & Marica Iommi. (2023) Pramipexole Augmentation for Treatment-Resistant Unipolar and Bipolar Depression in the Real World: A Systematic Review and Meta-Analysis. Life 13:4, pages 1043.
Crossref
John Cookson & Jonathan Pimm. (2021) Partial agonists of dopamine receptors: mechanisms and clinical effects of aripiprazole, brexpiprazole and cariprazine. BJPsych Advances 29:2, pages 145-150.
Crossref
Fraser Scott, Elliot Hampsey, Sam Gnanapragasam, Ben Carter, Lindsey Marwood, Rachael W Taylor, Cansu Emre, Lora Korotkova, Jonatan Martín-Dombrowski, Anthony J Cleare, Allan H Young & Rebecca Strawbridge. (2022) Systematic review and meta-analysis of augmentation and combination treatments for early-stage treatment-resistant depression. Journal of Psychopharmacology 37:3, pages 268-278.
Crossref
M. Ishrat Husain, Imran B. Chaudhry, Ameer B. Khoso, Tayyeba Kiran, Nawaz Khan, Farooq Ahmad, John Hodsoll, M. Omair Husain, Haider A. Naqvi, Asad T. Nizami, Nasim Chaudhry, Hazrat A. Khan, Fareed Minhas, Jeffrey H. Meyer, Moin A. Ansari, Benoit H. Mulsant, Nusrat Husain & Allan H. Young. (2023) Effect of Adjunctive Simvastatin on Depressive Symptoms Among Adults With Treatment-Resistant Depression. JAMA Network Open 6:2, pages e230147.
Crossref
Rebecca Strawbridge, Estefany Izurieta, Elana Day, Helena Tee, Kate Young, Co Co Tong, Allan H. Young & Anthony J. Cleare. (2023) Peripheral inflammatory effects of different interventions for treatment-resistant depression: A systematic review. Neuroscience Applied 2, pages 101014.
Crossref
Steven Marwaha, Edward Palmer, Trisha Suppes, Emily Cons, Allan H Young & Rachel Upthegrove. (2023) Novel and emerging treatments for major depression. The Lancet 401:10371, pages 141-153.
Crossref
Rebecca Strawbridge & Allan H Young. (2022) Lithium: balancing mental and renal health. The Lancet Psychiatry 9:10, pages 760-761.
Crossref
Yuki Furukawa, Saki Oguro, Satomi Obata, Tasnim Hamza, Edoardo G. Ostinelli & Kiyoto Kasai. (2022) Optimal dose of brexpiprazole for augmentation therapy of antidepressant‐refractory depression: A systematic review and dose‐effect meta‐analysis. Psychiatry and Clinical Neurosciences 76:9, pages 416-422.
Crossref
Yuki Furukawa, Tasnim Hamza, Andrea Cipriani, Toshi A. Furukawa, Georgia Salanti & Edoardo G. Ostinelli. (2021) Optimal dose of aripiprazole for augmentation therapy of antidepressant-refractory depression: preliminary findings based on a systematic review and dose–effect meta-analysis. The British Journal of Psychiatry 221:2, pages 440-447.
Crossref
Rebecca Strawbridge, Suman Kurana, Jess Kerr‐Gaffney, Sameer Jauhar, Kenneth R. Kaufman, Nefize Yalin & Allan H. Young. (2022) A systematic review and meta‐analysis of treatments for rapid cycling bipolar disorder. Acta Psychiatrica Scandinavica.
Crossref
Janet J. BaekEarth Hasassri. (2022) Ketamine for Adolescent Depression: An Overview and Considerations for Future Directions. American Journal of Psychiatry Residents' Journal 17:4, pages 2-4.
Crossref
Isaac Lage, Thomas H. McCoy Jr, Roy H. Perlis & Finale Doshi-Velez. (2022) Efficiently identifying individuals at high risk for treatment resistance in major depressive disorder using electronic health records. Journal of Affective Disorders 306, pages 254-259.
Crossref
Jan Jacobus Muit, Philip F P van Eijndhoven, Andrea Cipriani, Iris Dalhuisen, Suzanne van Bronswijk, Toshi A Furukawa & Henricus G Ruhe. (2022) Efficacy and acceptability of next step treatment strategies in adults with treatment-resistant major depressive disorder: protocol for systematic review and network meta-analysis. BMJ Open 12:4, pages e056777.
Crossref
Nicolas A Nuñez, Boney Joseph, Mehak Pahwa, Rakesh Kumar, Manuel Gardea Resendez, Larry J Prokop, Marin Veldic, Ashok Seshadri, Joanna M Biernacka, Mark A Frye, Zhen Wang & Balwinder Singh. (2022) Augmentation strategies for treatment resistant major depression: A systematic review and network meta-analysis. Journal of Affective Disorders 302, pages 385-400.
Crossref
Rebecca Strawbridge, Paul McCrone, Andrea Ulrichsen, Roland Zahn, Jonas Eberhard, Danuta Wasserman, Paolo Brambilla, Giandomenico Schiena, Ulrich Hegerl, Judit Balazs, Jose Caldas de Almeida, Ana Antunes, Spyridon Baltzis, Vladmir Carli, Vinciane Quoidbach, Patrice Boyer & Allan H. Young. (2022) Care pathways for people with major depressive disorder: A European Brain Council Value of Treatment study. European Psychiatry 65:1.
Crossref
Lasse Brandt, Andreas Heinz & Jonathan Henssler. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1173 1191 .
Roger S. McIntyre. (2021) Ketamine and Esketamine for Treatment-Resistant Depression: Response to Reus, Mattes, and Schatzberg. American Journal of Psychiatry 178:12, pages 1130-1132.
Crossref
Brett D. M. Jones, Lais B. Razza, Cory R. Weissman, Jewel Karbi, Tya Vine, Louise S. Mulsant, Andre R. Brunoni, M. Ishrat Husain, Benoit H. Mulsant, Daniel M. Blumberger & Zafiris J. Daskalakis. (2021) Magnitude of the Placebo Response Across Treatment Modalities Used for Treatment-Resistant Depression in Adults. JAMA Network Open 4:9, pages e2125531.
Crossref
Markus Dold, Lucie Bartova, Gernot Fugger, Alexander Kautzky, Marleen M.M. Mitschek, Chiara Fabbri, Stuart Montgomery, Joseph Zohar, Daniel Souery, Julien Mendlewicz, Alessandro Serretti & Siegfried Kasper. (2021) Melancholic features in major depression – a European multicenter study. Progress in Neuro-Psychopharmacology and Biological Psychiatry 110, pages 110285.
Crossref
Roger S. McIntyreJoshua D. RosenblatCharles B. NemeroffGerard SanacoraJames W. MurroughMichael BerkElisa BrietzkeSeetal DoddPhilip GorwoodRoger HoDan V. IosifescuCarlos Lopez JaramilloSiegfried KasperKevin KratiukJung Goo LeeYena LeeLeanna M.W. LuiRodrigo B. MansurGeorge I. PapakostasMehala SubramaniapillaiMichael ThaseEduard VietaAllan H. YoungCarlos A. ZarateJr.Jr. & Stephen Stahl. (2021) Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. American Journal of Psychiatry 178:5, pages 383-399.
Crossref
Lasse Brandt, Andreas Heinz & Jonathan Henssler. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 19 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.